Garry Neil owns 0.35% of Avalo Therapeutics
190,314 shares as of the May 21, 2026 filing, worth $2.1M at the latest close.
AVTX · $604M market capGet an email when Garry Neil’s stake moves.
Free.
The stake
0.35%
worth $2.1M at the latest close
Stake rank
#2,429
by dollar value of the stake
Last sale
None
no sales since 2020
Last buy
1,228 days ago
Jun 9, 2023 · $13,680
Garry Neil owns 0.35% of Avalo Therapeutics, Inc.: 190,314 of 53,629,989 shares, worth about $2.1M at the 2026-10-16 close. The stake has moved from 0.16% in 2020 to 0.35% on 2026-08-03, across 0 sales and 6 purchases that moved it since 2016. The last trade that moved it was a discretionary purchase of $13,680 on 2023-06-09.
How the stake is held
as of the May 21, 2026 filing
SHARES
OF THE STAKE
COMMON STOCK · stated May 21, 2026 · Form 4 ↗
HELD DIRECTLY
190,314
100.0%
THE STAKE
190,314
0.35%